In a meta-analysis of ATM variants, published by Tavtigian and colleagues (2009)30, they found marginal evidence that protein-truncating and splice-junction variants contribute to breast cancer risk, and stronger evidence that some evolutionary rare missense variants increase cancer risk. This evidence concerns the gene ATM and cancer.